{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:02:58Z","timestamp":1786118578860,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine Communications"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1097\/00006231-199802000-00007","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T15:26:12Z","timestamp":1164209172000},"page":"137-142","source":"Crossref","is-referenced-by-count":69,"title":["Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson\u02bcs disease"],"prefix":"10.1097","volume":"19","author":[{"given":"M.","family":"YOSHITA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"HAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"HIRAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006231-199802000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:11:00Z","timestamp":1786032660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-199802000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1097\/00006231-199802000-00007","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}